Biocon licenses 3 generic formulation products to China Medical Systems Holdings

This development is in line with Biocons long-term generic formulations strategy and expands the company's generic formulations business footprint to the Chinese pharmaceuticals market, which is the second largest pharmaceutical market in the world.

from India Infoline News Service https://ift.tt/30dOTGE